Skip to main content
Clinical Trials/DRKS00009637
DRKS00009637
Completed
未知

The neurochemical basis of individual pain sensitivity and pain modulation, Part II, Study 1 - Neurochem2

niversitätsklinikum Essen, Klinik für Neurologie0 sites70 target enrollmentNovember 26, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy Participants
Sponsor
niversitätsklinikum Essen, Klinik für Neurologie
Enrollment
70
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 26, 2015
End Date
April 28, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Essen, Klinik für Neurologie

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 40 years.
  • for women: hormonal contraception.
  • Written informed consent.

Exclusion Criteria

  • Signs of renal, cardiovascular, or hepatic disease.
  • Signs of raised intraocular pressure.
  • Protein\-rich diet before study\-visit one.
  • History of, or present neurologic disorders, e.g. pain disorders, migraine, lower back pain, irritable bowel syndrome, cranial trauma, epilepsia, or sleep disorder.
  • History of, or present psychiatric disorder, e.g. depression, schizophrenia, substance abuse, or personality disorders.
  • History of, or present severe internal disorders, such as diabetes, neoplasia, thyroid dysfunction, asthma.
  • Acute infections (common cold, diarrhea).
  • Alcohol consumtion at the day of or the day before study participation.
  • Known allergy against any constituent of the study medication.
  • Surgery requiring narcosis within the last 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials